摘要
目的:探讨舒血宁联用尼莫地平治疗椎基底动脉供血不足性眩晕的疗效。方法:收治椎基底动脉供血不足性眩晕患者82例,随机分为对照组和观察组各41例。对照组采用三磷酸苷联合辅酶A、尼莫地平治疗。观察组采用舒血宁联合尼莫地平治疗。结果:观察组总有效率高于对照组(P<0.05),治疗后,观察组患者的左椎动脉以及右椎动脉、基底动脉等的血流速度均有明显的提升,明显优于对照组(P<0.05)。结论:舒血宁联用尼莫地平治疗椎基底动脉供血不足性眩晕临床效果显著。
Objective:To evaluate the clinical efficacy of nimodipine combined with vertigo of vertebrobasilar ischemia treated with shuxuening.Methods:82 patients with vertigo of vertebrobasilar artery insufficiency were randomly divided into the control group and the observation group,with 41 cases in each group.The control group were treated with three phosphoric acid glycosides combined with coenzyme A and nimodipine.The observation group with Shuxuening combined with nimodipine treatment.Results:The total effective rate in the observation group was higher than that in the control group(P<0.05).After the treatment,the blood flow velocity of the left vertebral artery,right vertebral artery and basilar artery in the observation group was significantly improved,which was significantly better than that in the control group(P<0.05).Conclusion:Shuxuening injection combined with nimodipine in the treatment of vertebrobasilar insufficiency vertigo has remarkably clinical effect.
出处
《中国社区医师》
2018年第6期112-112,114,共2页
Chinese Community Doctors
关键词
舒血宁
尼莫地平
椎基底动脉供血不足性眩晕
临床疗效
Shuxuening
Nimodipine
Vertigo of vertebrobasilar artery insufficiency
Clinical efficacy